Treatment of Venous Thromboembolism in Real-Life Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

89383 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-12-04

Study Completion Date

2018-06-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In a population of patients with venous thromboembolism and treated with oral anticoagulants (OAC) in routine clinical practice in Denmark this study will describe patients treated with each OAC

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491

Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism

COMPLETED

Venous Thrombectomy/Thrombolysis Outcome Registry

NCT02113475

Deep Venous Thrombosis Post Thrombotic Syndrome

UNKNOWN

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

NCT02111564

Heart Failure Respiratory Insufficiency Stroke Acute +2 more

COMPLETED PHASE3

Risk Factors for Venous Thromboembolism in the Community

NCT00011180

Cardiovascular Diseases Thromboembolism

COMPLETED

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

NCT05795062

Venous Thromboembolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VKA patients

Vitamin K antagonist (VKA) patients

Non-Interventional

Intervention Type OTHER

Non-Interventional

NOAC patients

nonvitamin K antagonist oral anticoagulants (NOAC) patients

Non-Interventional

Intervention Type OTHER

Non-Interventional

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All patients ≥ 18 years diagnosed with incident VTE at Danish public hospitals from 2006 through 2015
2. First-time (index) VTE will be defined as an in- or out-patient diagnosis of DVT or PE among patients redeeming a prescription for anticoagulant drugs within 30 days after index date

Exclusion Criteria

1\. In the analyses on type and duration of anticoagulant use, Patients with cancer will be excluded as they typically receive low molecular heparin directly from the hospital and their use of anticoagulants can therefore not be captured by redeemed prescriptions at pharmacies.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No